Table 4.

Rate and rate ratio of selected comorbidities among 197 male patients with biopsy-proven GCA (cases) and 782 reference subjects (reference) matched for age, sex, and date of diagnosis.

ComorbidityGCA, n = 197Cases, Person-yrsRateReference, n = 782Reference, Person-yrsRateRate Ratio95% CIp
Ischemic heart disease15688963.0172376345.71.381.00–1.870.05
Cerebrovascular accidents13890541.995404523.41.791.19–2.610.01
Hypertension9570513532931141061.281.00–1.600.05
Diabetes mellitus3989643.5144364039.51.100.75–1.570.6
VTE115100614.91742603.993.741.74–7.950.006
Thyroid disease810147.892742056.421.230.48–2.780.6
Dyslipoproteinemias1799617.078401619.40.880.49–1.490.6
Psychiatric disease5390858.3220362060.70.960.70–1.300.7
Osteoporosis17100316.92042204.743.581.76–7.150.004
Fractures2596625.883404320.51.260.77–1.980.3
  • 1 Only inpatient diagnoses; all other diagnoses are for both inpatient and outpatient diagnoses. GCA: giant cell arteritis; VTE: venous thromboembolic diseases: pulmonary embolus and/or deep vein thrombosis.